| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $42.3M | +6.5% |
| Cost of Revenue | $28.7M | +27.4% |
| Gross Profit | $13.6M | -20.8% |
| R&D Expense | $85K | +0.0% |
| SG&A Expense | $3.5M | -8.1% |
| Operating Income | $9.3M | -26.3% |
| Interest Expense | $1.2M | +363.7% |
| Pre-tax Income | $8.7M | -29.6% |
| Income Tax | $2.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $103.8M | +5.8% |
| Accounts Receivable | $7.5M | +0.7% |
| Inventory | $112K | -49.4% |
| Current Assets | $114.1M | +6.9% |
| Total Assets | $128.0M | +7.0% |
| Current Liabilities | $3.0M | -53.5% |
| Total Liabilities | $3.4M | -48.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.1M | -91.6% |
| Capital Expenditures | $272K | -88.0% |
| Investing Cash Flow | -$272K | +88.0% |
| Financing Cash Flow | $7.6M | -81.0% |
| Free Cash Flow | $797K | -92.4% |
| -34.9% |
| Net Income | $6.0M | -27.0% |
| EPS (Basic) | $0.52 | -41.6% |
| EPS (Diluted) | $0.52 | -41.6% |
| Stockholders' Equity |
| $124.6M |
| +10.3% |